Skip to content

CytoDyn Inc.

CYDY· OTCCore metricsCIK 1175680

Pharmaceutical preparations552 peers

Close
Oct 29, 2026 · +9.52%
Market cap
$337.99M
1.47B shares
Filings
1,033
$0.00
FY 2023−100.0% FY23 yoy
-$19.94M
Q1 2027N/M FY26 yoy
-$6.58M
Q1 2027N/M FY26 yoy
-$71.71M
Q3 2022derivedN/M FY21 yoy
-$0.01
Q1 2027
$16.36M
Q1 2027−0.4% FY26 yoy
$337.99M
—
—
—
—
—

FY2026 figures · derived

Price

$0.238.00%$0.02past year
Oct 29, 2026 · Official close
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2023
$266.00K0FY 2021FY 2022FY 2023
PeriodEndedValueKindSource trail
FY 20232023-05-31$0reported
FY 20222022-05-31$266,000reported
FY 20212021-05-31$0reported

Segments

Segments
Operating income by Segments, FY2024 to FY2026FY2024FY2025Single reporting segment · FY2025 · $9.66MSingle reporting segment · FY2025 · $9.66MFY2026
LineFY2026ShareChange
Single reporting segment-$38.58M—N/M
Single reporting segment———
Total-$38.58M

From the 10-K filed Aug 31, 2026CYDY

Pharmaceutical preparations

CytoDyn Inc. is the 220th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

CytoDyn Inc. · CIK 1175680 · Engraved from SEC EDGAR